Mizar Therapeutics Inc.

Falmouth, MA Doing business as Mizar Therapeutics Inc.

UEI
QTYLAVN4EJR6
CAGE
9UUM6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
7 Mbl St, Woods Hole, MA 02543, USA
Website
mizartx.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Mizar Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir phase II - mizar s/TAR high-throughput platform for identification of senescence altering therapeutics Contract · 80NSSC25C0500 Shared Services Center $899,995
FY24 sbir phase i- mizar s/TAR high-throughput platform for identification of senescence altering therapeutics Contract · 80NSSC24PB376 Shared Services Center $155,536

Quick answers

What is Mizar Therapeutics Inc.'s UEI?

Mizar Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is QTYLAVN4EJR6.

What is Mizar Therapeutics Inc.'s CAGE code?

Mizar Therapeutics Inc.'s CAGE code is 9UUM6.

What is Mizar Therapeutics Inc.'s primary NAICS code?

Mizar Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Mizar Therapeutics Inc. located?

Mizar Therapeutics Inc.'s physical address in SAM.gov is 7 Mbl St, Woods Hole, MA 02543, USA.

Is Mizar Therapeutics Inc. registered in SAM.gov?

Yes. Mizar Therapeutics Inc.'s SAM.gov registration is active through July 20, 2027.

What is Mizar Therapeutics Inc.'s most recent federal award?

Mizar Therapeutics Inc.'s most recent federal contract award is Sbir phase II - mizar s/TAR high-throughput platform for identification of senescence altering therapeutics (80NSSC25C0500), from Shared Services Center, on September 29, 2025.

On GovTribe

See Mizar Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login